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Palliative care is effective: But hospital symptom outcomes superior
Abstract

Objectives: To explore differences in severe symptom outcomes for palliative care patients receiving hospital
care compared with those receiving care at home.
Methods: Change in symptom distress from the start of an episode of palliative care to just prior to death was
measured for 25 679 patients who died under the care of a hospital or home-based palliative care team
between January 2015 and December 2016. Logistic regression models controlled for differences between
hospital and home and enabled a comparison of the number of severe symptoms just prior to death.
Results: All symptoms improved and over 85% of all patients had no severe symptoms prior to death. Pain
control illustrates this with 7.4% of patients reporting severe pain distress at episode start and 2.5% just prior
to death. When comparing all symptom outcomes by place of death, hospital patients are 3.7 times more
likely than home patients to have no severe symptoms.
Conclusion: Symptom outcomes are better for hospital patients. Patients at home have less improvement
overall and some symptoms get worse. Reasons for the difference in outcomes by hospital and home are
multifactorial and must be considered in relation to the patient's right to choose their place of care.
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Objectives To explore differences in severe
symptom outcomes for palliative care patients
receiving hospital care compared with those
receiving care at home.
Methods Change in symptom distress from the
start of an episode of palliative care to just prior
to death was measured for 25 679 patients who
died under the care of a hospital or home-based
palliative care team between January 2015 and
December 2016. Logistic regression models
controlled for differences between hospital and
home and enabled a comparison of the number
of severe symptoms just prior to death.
Results All symptoms improved and over 85%
of all patients had no severe symptoms prior to
death. Pain control illustrates this with 7.4% of
patients reporting severe pain distress at episode
start and 2.5% just prior to death. When
comparing all symptom outcomes by place of
death, hospital patients are 3.7 times more likely
than home patients to have no severe symptoms.
Conclusion Symptom outcomes are better
for hospital patients. Patients at home have less
improvement overall and some symptoms get
worse. Reasons for the difference in outcomes
by hospital and home are multifactorial and must
be considered in relation to the patient’s right to
choose their place of care.

of care. In 2016, the PCOC data collection represented 12.4% of all deaths in
Australia (including unpredictable deaths)
and more than 80% of all patients seen
annually by specialist palliative care
services. An important role of PCOC is to
report on this repository of prospectively
collected information. Previously, PCOC
researchers have found that palliative care
services achieve statistically significant
improvements in pain and other symptoms2 and have described symptom prevalence at the time dying is diagnosed.3 In
those previous studies, the palliative care
phase2 3 was the unit of counting with the
outcome being the change from the beginning to the end of each phase.
Data presented here examine, for the
first time, the change in symptom scores
from the beginning of a palliative care
episode to just prior to death. Episodes
are defined by setting—either in a
hospital/hospice or at home—and consist
of one or more phases. The aim is to
compare symptom outcomes for people
receiving care in a hospital palliative care
unit or hospice (henceforth referred to
as a hospital episode) to those of people
receiving care at home (a home episode).

Across the healthcare spectrum, patients
and their families need evidence in order
to make informed choices about their care
needs. Palliative care is no exception, and
Australia is in a unique position internationally to provide such evidence.
The Australian Palliative Care Outcomes
Collaboration (PCOC) is a national
programme for palliative care services to
routinely measure and benchmark patient
outcomes.1 PCOC holds information
on the outcomes of more than 250 000
Australians who have received palliative
care over the last decade and the PCOC
clinical assessment model is now firmly
embedded into clinical practice at point

Methods
Over the last decade, palliative care
services across Australia have embedded
the PCOC clinical assessment framework as part of routine care in both
hospital and home settings.4 PCOC holds
outcome data representing more than 45
000 people receiving palliative care each
year.5 6 Physical symptom outcomes are
measured using the Symptom Assessment
Scale (SAS).7 SAS measures symptom
distress for each palliative care phase.8
For this analysis, the first phase SAS scores
are compared with final phase SAS scores
collected just prior to death. The SAS is
used by patients to rate distress relating
to seven physical symptoms (difficulty
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sleeping, appetite problems, nausea, bowel problems,
breathing problems, fatigue and pain). It is an 11-point
numeric rating scale ranging from 0 (no distress) to 10
(worst distress possible).1 7 In this study, only severe
SAS scores, categorised as 8–10, are used. Data are
collected directly from patients wherever possible, but
if this is not possible, clinical assessment ratings are
based on family/carers and clinical judgement. Proxy
assessments are accepted as a fair substitute for patient
responses when the patient is unable to contribute their
own view.9 10 Patient psychological/spiritual distress as
well as family/carer distress are included in the PCOC
assessment protocol but are not reported here.
Symptoms distress outcomes are defined in this analysis as the change in the number of severe symptoms
from the start to the end of an episode of care. In
hospital, an episode of care is the continuous period
of time from admission to death. In the community,
it is the continuous time between first assessment and
death. Patient episodes that end in transfer between
settings are excluded, as are patients receiving advisory
services from hospital consultation liaison teams.
The patient cohort includes all people who died
receiving the care of a hospital or home-based palliative care service between 1 January 2015 and 31
December 2016 and who had both an assessment at
episode start and another just prior to death. A requirement of inclusion in the study is that patients have data
completion for both study time points.
Logistic regression was used to investigate the
number of symptoms causing severe distress just prior
to death, controlling for the initial number of severely
distressing symptoms, setting of care (hospital/
home), age group, sex and life-limiting illness (cancer/
non-cancer). Having no severe symptoms just prior to
death was the measure of interest.
All data analysis was undertaken using SAS software
(SAS Institute, Cary, North Carolina, USA).
Results
A total of 40 004 patients in the PCOC database
died between January 2015 and December 2016. In
total, 25 679 (64%) met the criteria for inclusion in
this study and 14 365 (36%) did not. Episodes not
meeting inclusion criteria had clinical assessment data
at episode start but not at episode end. They fell into
two categories. There were 1620 (4.0%) consultation
liaison episodes. There were also 12 745 (31.8%)
other episodes with symptoms measured only once at
the start of the episode. These episodes were typically
late referrals. The median episode length was 3 days (2
days for hospital patients and 8 days for home patients)
and 79% were in the deteriorating or terminal phase at
their first (and only) assessment.
Table 1 shows the profile of the included patients.
Hospital was the most common place of death,
accounting for 76.6% of patients, with cancer being
the main reason people were receiving palliative care
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Table 1 Cohort characteristics
N
Female (%)
Malignant diagnosis (%)
Setting of care/place of death (%)
 Hospital palliative care unit/
hospice
 Home
 Residential aged care facility
 Community—not specified
Age (years)
 Mean
 SD
 Range

25 679
46.4
81.5
75.1
20.4
4.0
0.5
73.6
13.7
0–109

(80%). In the overall PCOC data set, the distribution
of episodes in hospital and home is roughly equal, but
is skewed towards hospitals in this analysis as people
are more likely to be admitted to hospital to die. This
is consistent with PCOC data (not reported here) on
the number of home palliative care episodes that end
with the patient being transferred to hospital.
The median time between last assessment and death
was 1 day in hospital and 2 days at home (table 2).
Although there were some differences by place of
death, the final phase was most likely to be the terminal
phase (85.3%). The median time between the first and
last assessment was 6 days for hospital/hospice and 21
days for home (table 2).
Table 3 summarises the results of the logistic regression, modelling the number of severe symptoms
just prior to death. When the other variables in the
model are held constant, patients in the hospital are
Table 2 Final palliative care phase type and length of phase
prior to death

Phase type (%)
 Stable
 Unstable
 Deteriorating
 Terminal
Time between
first and last
assessment
(days)1
 Median
 IQR
Time between last
assessment and
death (days)
 Median
 IQR

Entire cohort

Hospital (PCU/
hospice)

Community
(home/racf/
other)

(N=25 679)

(N=19 292)

(N=6387)

2.4
0.9
11.3
85.3

1.1
0.6
9.0
89.4

6.4
2.0
18.4
73.1

8
3–21

6
2–15

21
7–54

1
1–3

1
1–3

2
1–5
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Table 3

distress for each of the seven symptoms captured in the
SAS tool. People in their final days and hours experience less pain and other problems than earlier in their
illness. Fatigue is the most common symptom causing
distress and is more common than pain. Breathing
problems at end of life are also more common than
pain. In total, 7.4% of patients reported severe distress
from pain at episode start and only 2.5% in the last
few days of life. Distress from fatigue and lack of
appetite is not surprising as a loss of energy and appetite is common as death approaches while most pain
can be effectively managed. Other problems such as
distress from bowel problems (constipation, diarrhoea,
pain), difficulty sleeping and nausea are experienced
less often and these also typically improve as death
approaches.

Summary of logistic regression results

Severe symptoms at
start
 None
 One or more
Setting of care/place
of death
Hospital palliative care
unit / hospice
Home / residential aged
care facility
Age
 <55
 56–65
 66–75
 76–85
 86+
Sex
 Female
 Male
Life-limiting illness
 Cancer
 Non-cancer

OR

95% CI

5.232
1

(4.907 to 5.578)

3.772

(3.534 to 4.027)

1

1
1.511
2.283
3.367
3.916

(1.349 to 1.693)
(2.054 to 2.537)
(3.033 to 3.739)
(3.493 to 4.390)

0.958
1

(0.899 to 1.020)

4.256
1

(3.980 to 4.550)

Discussion
Severe pain and symptom outcomes are better for
hospital patients. Patients at home have less improvement overall and some symptoms get worse. Pain and
symptom control are fundamental to palliative care.
Pain and symptom control are key reasons for a palliative care referral, and they are also core domains that
patients and families use to judge the care that they
receive. Our key findings are twofold. First, higher
levels of severe symptom distress reported at the start
of palliative care reduce significantly. Second, those
who die at home experience less improvement overall
and distress from fatigue and breathing problems get
worse. The reasons for the increase in these symptoms
may be due to environmental or individual factors or
both.
Reasons for the differences in symptom outcomes
between hospital and home are multifactorial. This
cohort includes patients who choose their place of care

3.7 times as likely than those at home to have no
severely distressing symptoms just prior to death. Similarly, patients with cancer are 4.3 times as likely than
those with non-cancer diagnosis to have no severely
distressing symptoms just prior to death.
One quarter of all palliative care patients (26.0%)
reported having severe distress from at least one
symptom at the start of their palliative care episode.
This decreased to 13.9% just prior to death. Figure 1
shows the percentage of patients reporting severe
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Severe symptoms at episode start and just prior to death.
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and their place of death as well as those who do not.
Some elect home palliative care and a home death and
some elect to be admitted to hospital at end of life.
Other patients effectively have little choice because
they are admitted to palliative care for terminal care
due to factors such as late identification of needs and
late referral to palliative care.
When physical symptoms exceed the intensity of
care that can be delivered in the community, people are
frequently admitted to hospital for symptom management. National PCOC data confirm this with 74%
patients being admitted to hospital in the unstable or
deteriorating phase,5 an indication of higher symptom
needs. In consequence, symptoms at the start of a
hospital episode are more severe (figure 1) and therefore there is more room for improvement compared
with home-based care.
Care at home requires families and healthcare
professionals (including a family physician) to provide
adequate support.11 12 For some patients, this might not
be achievable on any sustainable basis. Not all community palliative care can offer a rapid response service on
a 24 hours 7 days basis and access to medical resources
is often limited relative to availability in hospitals.
A person’s wishes and choices regarding end-oflife care also impact their outcomes. Not everyone
wants to go to hospital in their final stages of life and
many people would prefer to be at home.13 14 Another
consideration is that some people elect little or no
pain relief and others elect to stay at home even if pain
and symptom control might be better if they were in
hospital.
Conclusion
Australian palliative care is leading the world in
having a national system of routine patient outcome
measurement and benchmarking using point-of-care
assessment of symptoms. The PCOC data demonstrate
that those receiving care in a hospital with designated
palliative care services have better pain and symptom
control than those receiving palliative care at home.6
This current analysis lends further weight to this
conclusion.
This study raises a number of issues for further
exploration. This includes the need to undertake
further work exploring the impact of proxy scores on
symptom outcomes as final ratings just prior to death
are more likely to be provided by proxies. This work is
already in progress.
Although it is difficult in an observational study
to attribute change to an intervention, the results
presented here are consistent with PCOC data
collected nationally for more than a decade, which
show both significant improvement nationally year on
year while at the same time finding consistently better
symptom management in the hospital setting. Significant work is now in progress to better understand the
effect of model of care and resources on outcomes in

4

both settings. This includes an exploration of service
level features that lead to improvement, including the
relationship between key service characteristics and
outcomes.
While it is not possible to be definitive about the
reasons for the difference in outcomes between hospital
and home, a better understanding of this is crucial for
policy and service development. Differences in patient
outcomes need to be taken into account in formulating
national palliative care policies and in service planning.
At the clinical level, this information is critical to allow
patients and families to make informed choices about
the best place for their care.
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